China Pharma Holdings (CPHI) Change in Cash (2010 - 2026)
China Pharma Holdings (CPHI) posted Change in Cash of -$176638.0 for Q1 2026, down 327.96% on a QoQ basis from $77487.0 in Q4 2025, and up 17.53% year-over-year from -$150288.7 in Q1 2025.
China Pharma Holdings (CPHI) Change in Cash (2010 - 2026) Analysis & Trends
China Pharma Holdings' Change in Cash history runs 17 years deep, the most recent figure standing at -$176638.0 for Q1 2026.
- Quarterly Change in Cash rose 17.53% year-over-year to -$176638.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$244214.0 (up 42.7% YoY) and the FY2025 annual result came in at -$281767.0, up 64.64% from the prior year.
- Change in Cash was -$176638.0 for Q1 2026 at China Pharma Holdings, down from $77487.0 in the prior quarter.
- Across five years, Change in Cash topped out at $467961.0 in Q3 2023 and bottomed at -$1.5 million in Q2 2022.
- A 5-year average of -$275916.8 and a median of -$158664.0 in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash soared 394.94% — and 2025, when it slumped 1631.12%.
- China Pharma Holdings' Change in Cash stood at -$56327.0 in 2022, then jumped by 195.81% to $53967.0 in 2023, then tumbled by 270.13% to -$91812.0 in 2024, then soared by 184.4% to $77487.0 in 2025, then sank by 327.96% to -$176638.0 in 2026.
- Business Quant data shows CPHI's Change in Cash at -$176638.0 in Q1 2026, $77487.0 in Q4 2025, and -$357407.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -176,638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176,638.00 |
| Dec 31, 2025 | 77,487.00 |
| Sep 30, 2025 | -357,407.00 |
| Jun 30, 2025 | 212,344.00 |
| Mar 31, 2025 | -214,191.00 |
| Dec 31, 2024 | -91,812.00 |
| Sep 30, 2024 | -20,646.00 |
| Jun 30, 2024 | -99,544.00 |
| Mar 31, 2024 | -584,957.00 |
| Dec 31, 2023 | 53,967.00 |
| Sep 30, 2023 | 467,961.00 |
| Jun 30, 2023 | -265,037.00 |
| Mar 31, 2023 | -863,024.00 |
| Dec 31, 2022 | -56,327.00 |
| Sep 30, 2022 | -158,664.00 |
| Jun 30, 2022 | -1.47 Mn |
| Mar 31, 2022 | -1.14 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | 1.22 Mn |